In this issue, we present another installment of our quarterly review of dealmaking—for January-March 2007. Our data comes from Windhover's Strategic Transactions Database, which covers deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics and research industries.
The total pharma IPO money raised in 1Q 2007 was $511 million, down 37% from the previous quarter. Only four...